EW vs. RMD: Edwards Lifesciences vs. ResMed Stock Comparison
How do Edwards Lifesciences (EW) and ResMed (RMD) stack up? This page sets them side by side across company profile, performance and risk, profitability, growth, financial strength, dividends, and valuation, with selected fundamentals also measured against each stock's industry-group peers.
Company Profile
Edwards Lifesciences (EW) and ResMed (RMD) are both classified in the Health Care Equipment sub-industry within the broader Health Care Equipment & Supplies industry, placing them in the closest GICS peer bucket.
| Profile Item | EW | RMD |
|---|---|---|
| Name | Edwards Lifesciences Corporation | ResMed Inc. |
| Country/Region | United States | United States |
| GICS Sector | Health Care | Health Care |
| GICS Industry Group | Health Care Equipment & Services | Health Care Equipment & Services |
| GICS Industry | Health Care Equipment & Supplies | Health Care Equipment & Supplies |
| GICS Sub-Industry | Health Care Equipment | Health Care Equipment |
| Market Capitalization | 58.73 billion USD | 33.10 billion USD |
| Currency | USD | USD |
| Exchange | NYSE | NYSE |
| Listing Date | March 27, 2000 | June 2, 1995 |
| Security Type | Common Stock | Common Stock |
Price Performance
Cumulative Growth
Trailing Returns
Calendar-Year Returns
Performance Metrics
| Metric | EW | RMD |
|---|---|---|
| Total Return (1Y) | 25.08% | -5.42% |
| Total Return (3Y, Annualized) | 17.28% | 18.99% |
| Total Return (5Y, Annualized) | -2.77% | -1.23% |
Risk Profile
Drawdown History
Return Distribution
Risk Metrics
| Metric | EW | RMD |
|---|---|---|
| Volatility (1Y, Annualized) | 25.58% | 30.80% |
| Beta (5Y) | 0.78 | 0.75 |
| Max Drawdown (5Y) | -54.32% | -49.04% |
| Avg. Volume (3M) | 3.69M | 1.32M |
Risk-Adjusted Performance
Risk-Return Positioning
Risk-Adjusted Metrics
| Metric | EW | RMD |
|---|---|---|
| Sharpe Ratio (1Y) | 0.81 | -0.31 |
| Sortino Ratio (1Y) | 1.23 | -0.43 |
Profitability
ROE (TTM)
ResMed (RMD) at 26.40% sits in the top ROE quartile, while Edwards Lifesciences (EW) at 9.33% is closer to the peer norm — stronger capital efficiency for RMD.
EW
Health Care Equipment & Services industry group
9.33%
- Max
- 47.61%
- Q3
- 14.36%
- EW
- 9.33%
- Median
- 5.45%
- Q1
- -10.67%
- Min
- -47.01%
RMD
Health Care Equipment & Services industry group
26.40%
- Max
- 47.61%
- RMD
- 26.40%
- Q3
- 14.36%
- Median
- 5.45%
- Q1
- -10.67%
- Min
- -47.01%
Net Margin (TTM)
For every dollar of sales, both Edwards Lifesciences (EW) at 15.30% and ResMed (RMD) at 27.79% retain more as net profit than most peers, landing in the top net margin quartile of their industries.
EW
Health Care Equipment & Services industry group
15.30%
- Max
- 29.35%
- EW
- 15.30%
- Q3
- 9.33%
- Median
- 2.18%
- Q1
- -6.29%
- Min
- -28.46%
RMD
Health Care Equipment & Services industry group
27.79%
- Max
- 29.35%
- RMD
- 27.79%
- Q3
- 9.33%
- Median
- 2.18%
- Q1
- -6.29%
- Min
- -28.46%
Operating Margin (TTM)
Both Edwards Lifesciences (EW) at 30.15% and ResMed (RMD) at 34.82% convert sales into operating profit at a top-quartile rate, pointing to tighter cost discipline before financing and tax.
EW
Health Care Equipment & Services industry group
30.15%
- Max
- 35.43%
- EW
- 30.15%
- Q3
- 14.14%
- Median
- 6.81%
- Q1
- -0.28%
- Min
- -16.29%
RMD
Health Care Equipment & Services industry group
34.82%
- Max
- 35.43%
- RMD
- 34.82%
- Q3
- 14.14%
- Median
- 6.81%
- Q1
- -0.28%
- Min
- -16.29%
Profitability Metrics
| Metric | EW | RMD |
|---|---|---|
| ROE (TTM) | 9.33% | 26.40% |
| ROA (TTM) | 8.77% | 14.76% |
| Net Margin (TTM) | 15.30% | 27.79% |
| Operating Margin (TTM) | 30.15% | 34.82% |
| Gross Margin (TTM) | 78.02% | 61.77% |
Growth
Revenue Growth
Both Edwards Lifesciences (EW) at 11.55% and ResMed (RMD) at 9.85% land near their industries' usual revenue growth ranges, so top-line momentum looks broadly in line with peers on both sides.
EPS Growth
Only one side can be read here: Edwards Lifesciences (EW) reports EPS growth of -73.74%, ranked against its industry; ResMed (RMD) has no EPS growth figure this period.
Growth Metrics
| Metric | EW | RMD |
|---|---|---|
| Revenue Growth (YoY) | 11.55% | 9.85% |
| Revenue Growth (3Y CAGR) | 10.77% | 10.21% |
| EPS Growth (YoY) | -73.74% | -- |
| EPS Growth (3Y CAGR) | -9.14% | 19.64% |
Financial Strength
Current Ratio (MRQ)
ResMed (RMD) at 2.65 keeps current ratio within its industry’s typical mid-range, while Edwards Lifesciences (EW) at 4.60 sits above its industry’s typical mid-range — comfortable liquidity, though possibly with more idle current assets relative to peers.
EW
Health Care Equipment & Services industry group
4.60
- Max
- 7.59
- EW
- 4.60
- Q3
- 4.00
- Median
- 1.98
- Q1
- 1.37
- Min
- 0.30
RMD
Health Care Equipment & Services industry group
2.65
- Max
- 7.59
- Q3
- 4.00
- RMD
- 2.65
- Median
- 1.98
- Q1
- 1.37
- Min
- 0.30
Debt / Equity (MRQ)
Both Edwards Lifesciences (EW) at 0.06 and ResMed (RMD) at 0.10 keep leverage in the lower quartile of their industries, with less balance-sheet debt relative to equity than most peers.
EW
Health Care Equipment & Services industry group
0.06
- Max
- 1.88
- Q3
- 0.91
- Median
- 0.58
- Q1
- 0.16
- EW
- 0.06
- Min
- 0.00
RMD
Health Care Equipment & Services industry group
0.10
- Max
- 1.88
- Q3
- 0.91
- Median
- 0.58
- Q1
- 0.16
- RMD
- 0.10
- Min
- 0.00
Financial Strength Metrics
| Metric | EW | RMD |
|---|---|---|
| Current Ratio (MRQ) | 4.60 | 2.65 |
| Debt / Equity (MRQ) | 0.06 | 0.10 |
| Net Debt / EBITDA | -1.88 | -0.19 |
Dividends
Dividend Yield (TTM)
Edwards Lifesciences (EW) pays no dividend (yield 0.00%) — it may be reinvesting, using buybacks, or simply not returning cash through dividends. Meanwhile ResMed (RMD) reports a yield of 1.03%, ranking against industry peers normally.
EW
Health Care Equipment & Services industry group
0.00%
- EW
- 0.00%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
RMD
Health Care Equipment & Services industry group
1.03%
- RMD
- 1.03%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
Dividend Payout Ratio (TTM)
Edwards Lifesciences (EW) pays no dividend (payout 0.00%) — it may be reinvesting, using buybacks, or simply not returning cash through dividends. Meanwhile ResMed (RMD) reports a payout of 22.40%, ranking against industry peers normally.
EW
Health Care Equipment & Services industry group
0.00%
- EW
- 0.00%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
RMD
Health Care Equipment & Services industry group
22.40%
- RMD
- 22.40%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
Dividend Metrics
| Metric | EW | RMD |
|---|---|---|
| Dividend Yield (TTM) | 0.00% | 1.03% |
| Dividend Payout Ratio (TTM) | 0.00% | 22.40% |
Valuation
P/E Ratio (TTM)
ResMed (RMD) at 21.43 is near its industry’s usual P/E ratio, while Edwards Lifesciences (EW) at 59.38 sits in the richer quartile — EW needs stronger growth or earnings quality to justify the premium.
EW
Health Care Equipment & Services industry group
59.38
- Max
- 80.41
- EW
- 59.38
- Q3
- 47.62
- Median
- 29.93
- Q1
- 21.19
- Min
- 4.21
RMD
Health Care Equipment & Services industry group
21.43
- Max
- 80.41
- Q3
- 47.62
- Median
- 29.93
- RMD
- 21.43
- Q1
- 21.19
- Min
- 4.21
P/S Ratio (TTM)
Both Edwards Lifesciences (EW) at 8.80 and ResMed (RMD) at 5.77 command a richer price per dollar of sales than most peers, sitting in the upper P/S ratio quartile of their industries.
EW
Health Care Equipment & Services industry group
8.80
- EW
- 8.80
- Max
- 8.80
- Q3
- 4.32
- Median
- 2.13
- Q1
- 1.10
- Min
- 0.03
RMD
Health Care Equipment & Services industry group
5.77
- Max
- 8.80
- RMD
- 5.77
- Q3
- 4.32
- Median
- 2.13
- Q1
- 1.10
- Min
- 0.03
P/B Ratio (MRQ)
On P/B ratio, both Edwards Lifesciences (EW) at 5.41 and ResMed (RMD) at 5.56 are valued close to their industries’ norm against book — neither stands out from peers.
EW
Health Care Equipment & Services industry group
5.41
- Max
- 11.68
- Q3
- 6.12
- EW
- 5.41
- Median
- 3.00
- Q1
- 1.73
- Min
- -1.31
RMD
Health Care Equipment & Services industry group
5.56
- Max
- 11.68
- Q3
- 6.12
- RMD
- 5.56
- Median
- 3.00
- Q1
- 1.73
- Min
- -1.31
Valuation Metrics
| Metric | EW | RMD |
|---|---|---|
| P/E Ratio (TTM) | 59.38 | 21.43 |
| P/S Ratio (TTM) | 8.80 | 5.77 |
| P/B Ratio (MRQ) | 5.41 | 5.56 |
| Free Cash Flow Yield (TTM) | 1.95% | 3.92% |